What is already known
- Evogliptin is a DPP-4 inhibitor used as treatment for type 2 diabetes
mellitus.
- Many guidelines recommend the use of combination therapy as treatment
for type 2 diabetes mellitus.
- Unlike evogliptin and metformin, no data is available on the drug
interaction of evogliptin and sulfonylurea.